InnoTek Limited Receives SGX-ST Approval for Proposed Share Placement
InnoTek Limited Receives Approval for S\$16 Million Share Placement on SGX
Key Developments
- Proposed Placement: InnoTek Limited announced that it has received approval in-principle from the Singapore Exchange Securities Trading Limited (SGX-ST) to proceed with the issuance and listing of up to 24,600,372 new ordinary shares at a placement price of S\$0.6506 per share.
- Potential Fundraising: This placement could raise gross proceeds of approximately S\$16 million for the company, assuming all shares are placed out.
- SGX-ST Approval Date: The approval was granted on 13 April 2026. The shares must be placed out within seven market days from this date.
Key Conditions Attached to the Approval
The SGX-ST’s approval in-principle is subject to several important conditions that both the company and the placement agent must fulfill:
- InnoTek must provide a written undertaking to comply with Rules 704(30) and 1207(20) of the SGX Listing Manual. This means the company must disclose detailed breakdowns on the use of placement proceeds, especially when allocated for working capital, in its official announcements and annual reports.
- The company and placement agent must each provide confirmations that they will comply with Rule 803 of the Listing Manual (which restricts the issue of shares to certain parties).
- Both the company and the placement agent must confirm that no shares will be allocated to prohibited persons as specified under Rule 812(1) of the Listing Manual.
What Shareholders Need to Know
- Placement Not Yet Finalized: The proposed placement remains subject to the fulfillment of several conditions, including those in the placement agreement. There remains a risk that the placement may not proceed if these conditions are not met.
- Potential Share Price Impact: The issuance of up to 24.6 million new shares, representing a significant increase in share capital, could potentially have a dilutive effect on existing shareholders. However, the injection of new capital may also support future growth, depending on how the proceeds are used.
- Disclosure on Use of Proceeds: Investors should monitor future announcements, as the company is required to provide specific details on how placement proceeds will be used, especially for working capital.
- Regulatory Compliance: The placement process is being closely monitored under SGX rules to ensure transparency and fairness in allocation.
Next Steps and Cautionary Notes
- The company will continue to provide updates on key developments and progress relating to the Proposed Placement.
- Shareholders and potential investors are advised to exercise caution, as there is no certainty that the placement will be completed successfully.
- Persons uncertain about their investment decisions should consult professional advisors.
Summary
The approval from SGX-ST for InnoTek Limited’s proposed share placement is a significant development and could be price-sensitive, given the potential S\$16 million capital injection and the corresponding dilution effect. The market’s reaction will likely depend on further disclosures regarding the use of proceeds and the successful completion of the placement process.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Shareholders and investors should review all company announcements and consult their professional advisors before making investment decisions. The proposed placement remains subject to conditions and may not proceed as planned.
View InnoTek Historical chart here